DERMAGENE
Live / Applied — Statement of use — registration review complete (as of 19 Oct 2026)
What this means for you
Not registered yet, but its 03 Oct 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97617337
- Mark type
- Word mark
- Filed
- 03 Oct 2022
- Published for opposition
- 18 Jul 2023
- Attorney of record
- Patrick C. Asplin
Goods and services
- Class 044 — Medical, beauty and agricultural services: Medical information services, namely, providing reports and information relating to disease activity in individuals suffering from psoriasis, atopic dermatitis, scleroderma or Lupus; providing reports and information relating to the best drug therapies and treatment options for individuals suffering from psoriasis, atopic dermatitis, scleroderma or Lupus based on their genetic profile and gene expression
Owner
- Ampel, LLC, Charlottesville, VA, US
- Ampel, LLC, Charlottesville, VA, US
Prosecution history
- 19 Oct 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Oct 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Oct 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Aug 2026 — USE AMENDMENT FILED
- 14 Sept 2026 — TEAS STATEMENT OF USE RECEIVED
- 23 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jul 2026 — SOU EXTENSION 5 GRANTED
- 12 Mar 2026 — SOU EXTENSION 5 FILED
- 22 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Sept 2025 — SOU EXTENSION 4 GRANTED
- 11 Sept 2025 — SOU EXTENSION 4 FILED
- 11 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED